0RB1 Stock Overview
A pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Laboratorio Reig Jofre, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.86 |
| 52 Week High | €3.18 |
| 52 Week Low | €2.23 |
| Beta | 0.89 |
| 11 Month Change | -5.30% |
| 3 Month Change | 4.38% |
| 1 Year Change | 17.70% |
| 33 Year Change | -21.43% |
| 5 Year Change | 19.77% |
| Change since IPO | -52.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0RB1 | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | -3.1% | 5.0% | 1.7% |
| 1Y | 17.7% | 2.2% | 8.3% |
Return vs Industry: 0RB1 exceeded the UK Pharmaceuticals industry which returned 2.2% over the past year.
Return vs Market: 0RB1 exceeded the UK Market which returned 8.3% over the past year.
Price Volatility
| 0RB1 volatility | |
|---|---|
| 0RB1 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0RB1's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0RB1's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1929 | 1,323 | Ignasi Reig | www.reigjofre.com |
Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the Forté Pharma brand.
Laboratorio Reig Jofre, S.A. Fundamentals Summary
| 0RB1 fundamental statistics | |
|---|---|
| Market cap | €225.77m |
| Earnings (TTM) | €9.55m |
| Revenue (TTM) | €333.69m |
23.6x
P/E Ratio0.7x
P/S RatioIs 0RB1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0RB1 income statement (TTM) | |
|---|---|
| Revenue | €333.69m |
| Cost of Revenue | €144.54m |
| Gross Profit | €189.15m |
| Other Expenses | €179.60m |
| Earnings | €9.55m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 56.68% |
| Net Profit Margin | 2.86% |
| Debt/Equity Ratio | 24.7% |
How did 0RB1 perform over the long term?
See historical performance and comparison